← FDA Drug Approvals (Drugs@FDA)
ENZALUTAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2022-04-22
Drug application
- FDA Application #
ANDA209645- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ENZALUTAMIDE
- Generic name
- Enzalutamide
- Active ingredients
- ENZALUTAMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2022-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown